Clinical Trials Update: Sept. 26, 2006
Urinary Tract Infections Insomnia Adenocarcinoma
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Urinary Tract Infections
This is a research study of an investigational oral medication for lower urinary tract symptoms associated with enlarged prostate. These symptoms may include frequency urination, retaining urine, or urinary pain. You must be at least 45 to qualify.
The research site is in Huntsville, Ala.
This study will evaluate an investigational medication for insomnia. You may qualify if you are 18 or older, have difficulty staying asleep, and have daytime sleepiness. Participants will receive investigational medication or a placebo and study-related physical exam at no cost, and compensation for time and travel.
The research site is in Philadelphia.
This study will compare adjuvant hormonal therapy with adjuvant chemohormonal therapy in women whose tumors meet established clinical guidelines and who fall into a "primary study group" category (Oncotype DX Recurrence score 11-25). Women 18-75 who have been diagnosed with adenocarcinoma of the breast, are estrogen and/or progesterone positive, and who are disease-free of prior invasive malignancies for greater than five years with certain exceptions may qualify. People with a previous invasive breast cancer or bilateral synchronous cancer are not eligible.
The research site is in Poughkeepsie, NY.
Copyright 2006 Thomson CenterWatch. All rights reserved.